Found: 10
Select item for more details and to access through your institution.
Individual Life-Course Socioeconomic Position and Hearing Aid Use in the Atherosclerosis Risk in Communities Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Longitudinal Blood Pressure Patterns From Mid- to Late Life and Late-Life Hearing Loss in the Atherosclerosis Risk in Communities Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association of Cigarette Smoking Patterns Over 30 Years With Audiometric Hearing Impairment and Speech-in-Noise Perception: The Atherosclerosis Risk in Communities Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Assessing the effect of body mass index on perioperative outcomes and short-term recurrence after paraesophageal hernia repair.
- Published in:
- Diseases of the Esophagus, 2024, v. 37, n. 11, p. 1, doi. 10.1093/dote/doae072
- By:
- Publication type:
- Article
Patient-Reported Experiences of Breast Cancer Screening, Diagnosis, and Treatment Delay, and Telemedicine Adoption during COVID-19.
- Published in:
- Current Oncology, 2022, v. 29, n. 8, p. 5919, doi. 10.3390/curroncol29080467
- By:
- Publication type:
- Article
1271-PUB: Real-World Effectiveness of Newly Initiated Once-Weekly Semaglutide (sema OW) by Prescriber Specialty.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1271-PUB
- By:
- Publication type:
- Article
86-LB: Real-World Effectiveness of Oral Semaglutide (OS) from a U.S. Commercially Insured and Medicare Advantage Population.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-86-LB
- By:
- Publication type:
- Article
683-P: Real-World Evaluation of Once-Weekly Semaglutide (Sema OW) in Patients Newly Initiating GLP-1 Agonist Therapy.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-683-P
- By:
- Publication type:
- Article
652-P: Real-World Effectiveness of Once-Weekly Semaglutide (sema OW) from a U.S. Commercially Insured and Medicare Advantage Population.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-652-P
- By:
- Publication type:
- Article
653-P: Evaluating Antidiabetic Medication Treatment Patterns in T2D Patients Initiating Once-Weekly Semaglutide (sema OW).
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-653-P
- By:
- Publication type:
- Article